Key Takeaways Solventum (SOLV) posted a strong Q1 FY25 with 4.3% organic growth and raised full-year revenue guidance. SOLV's growth is driven by improved commercial focus and product innovation in MedSurg, Dental, and HIS. Tariff risks loom, but SOLV's strategic mitigations to support sustained profitability.Solventum Corporation (SOLV) delivered a robust first-quarter performance, reflecting the company’s progress on its multi-phase transformation and renewed commercial focus. The company reported earni ...

Solventum (SOLV) reported first-quarter 2025 adjusted earnings per share (EPS) of $1.34, which beat the Zacks Consensus Estimate of $1.19 by 12.6%. The bottom line declined 35.6% year over year.GAAP EPS in the quarter was 78 cents, down 43.1% from the year-ago quarter’s level. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.)Revenue DetailsThe company reported revenues of $2.07 billion, up 2.6% reportedly from the prior-year recorded number. Organically, sales were up 4.3%. The met ...

Q1 FY25 earnings presentation May 8, 2025 © Solventum 2025. All rights reserved. Forward-looking statements and use of document This presentation and other materials Solventum has filed or will file with the U.S. Securities & Exchange Commission ("SEC") (and oral communications that Solventum may make) contain or incorporate by reference statements that relate to future events and expectations and, as such, constitute forward-looking statements that involve risk and uncertainties. Forward-looking statements ...

Solventum (SOLV) is scheduled to release first-quarter 2025 results on May 8, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 7.63%. SOLV delivered a trailing four-quarter average earnings surprise of 14.47%.SOLV Q1 EstimatesCurrently, the consensus estimate for revenues is pegged at $2 billion. The consensus mark for earnings is pinned at $1.19 per share. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.)Factors to NoteS ...

Solventum Corporation (SOLV) partnered with SprintRay to introduce a groundbreaking solution for digital dentistry, enabling high-quality, same-day dental restorations. This innovative partnership aims to transform dental care by leveraging advanced 3D printing technology, allowing dentists to produce durable restorations with precision and efficiency. With this collaboration, Solventum reinforces its commitment to advancing dental solutions through cutting- edge innovation. By reducing turnaround time and ...

Solventum Corporation (NYSE:SOLV) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations and External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler & Co. Patrick Wood - Morgan Stanley David Roman - Goldman Sachs Group, Inc. Travis Steed - Bank of America Vikramjeet Chopra - Wells Fargo Securities Frederick Wis ...